Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

Infant Formula Intolerance Clinical Trial

Official title:
Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study

Status Completed

Clinical Trial Summary

A single center, non-controlled trial to document the gastrointestinal (GI) tolerability of the study formula (SF), containing a whey protein concentrate enriched with alpha-lactalbumin (WPC alpha-lac) fed for 6 weeks to healthy, term infants.

Clinical Trial Description

The purpose of this study is to examine the tolerable and acceptability of an infant formula with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance, and eating behaviors. ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Infant Formula Intolerance

Clinical Trial Details

NCT number	NCT02431377
Study type	Interventional
Source	Nestlé
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	October 2015

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02363582` - The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants	N/A
	Recruiting	`NCT03178474` - Efficacy of JINLINGGUAN and TOFER Formula in Formula-fed Chinese Term Infants	N/A